<\/p>\n
Sa\u011fl\u0131k Bilimleri \u00dcniversitesi (SB\u00dc) T\u0131p Fak\u00fcltesi Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Ana Bilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. \u0130lyas D\u00f6kmeta\u015f, AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, k\u0131zam\u0131k hastal\u0131\u011f\u0131n\u0131, “daha \u00e7ok \u00e7ocukluk \u00e7a\u011f\u0131nda ge\u00e7irilen, ate\u015fli, d\u00f6k\u00fcnt\u00fcl\u00fc, komplikasyonlar\u0131 ve istenmeyen etkileri olabilen, \u00f6l\u00fcme ve salg\u0131na yol a\u00e7abilen viral enfeksiyon” diye tan\u0131mlad\u0131.<\/p>\n
\u00c7ocukken a\u015f\u0131lanmayan ki\u015filerin eri\u015fkin ya\u015flarda da k\u0131zam\u0131k ge\u00e7irebildi\u011fini s\u00f6yleyen D\u00f6kmeta\u015f, toplumda uygun \u015fekilde a\u015f\u0131lar yap\u0131l\u0131rsa \u00e7ocukluk \u00e7a\u011f\u0131ndan itibaren k\u0131zam\u0131\u011f\u0131n neredeyse hi\u00e7 g\u00f6r\u00fclmeyece\u011fini anlatt\u0131.<\/p>\n
Prof. Dr. D\u00f6kmeta\u015f, a\u015f\u0131n\u0131n yap\u0131ld\u0131\u011f\u0131 ya\u015fa ve aral\u0131\u011f\u0131na ba\u011fl\u0131 olarak y\u00fczde 98-99 oran\u0131nda koruyucu oldu\u011funa dikkati \u00e7ekerek, sadece bireyin de\u011fil toplumun korunmas\u0131 i\u00e7in a\u015f\u0131lanma oran\u0131n\u0131n y\u00fczde 90’larda olmas\u0131 gerekti\u011fini vurgulad\u0131.<\/p>\n
A\u015f\u0131lanmayan \u00e7ocuklar\u0131n oran\u0131 y\u00fckseldi\u011fi takdirde a\u015f\u0131 olanlar\u0131n da k\u0131zam\u0131k ge\u00e7irilebilece\u011fini ancak bu ki\u015filerde hastal\u0131\u011f\u0131n daha hafif seyredebilece\u011fini, komplikasyonlar ve \u00f6l\u00fcmler olmayabilece\u011fini belirten D\u00f6kmeta\u015f, a\u015f\u0131s\u0131z olanlarda ise zat\u00fcrre ve beyin iltihaplanmalar\u0131ndan dolay\u0131 \u00f6l\u00fcmler g\u00f6r\u00fclebilece\u011fini kaydetti.<\/p>\n
D\u00f6kmeta\u015f, son zamanlarda a\u015f\u0131lanma oran\u0131n\u0131n biraz d\u00fc\u015ft\u00fc\u011f\u00fcn\u00fcn s\u00f6ylendi\u011fini aktararak, “K\u0131zam\u0131k vakalar\u0131nda eskiye g\u00f6re bir art\u0131\u015f\u0131m\u0131z var. Son 1-1,5 y\u0131ldan beri k\u0131zam\u0131k vakalar\u0131n\u0131 zaman zaman g\u00f6zlemliyoruz. T\u00fcrkiye \u00e7ap\u0131nda bundan 1, 2, 3 y\u0131l \u00f6ncesine kadar vakalar 10’lu rakamlara do\u011fru inmi\u015fken, \u015fimdi 500’\u00fcn \u00fczerine do\u011fru \u00e7\u0131kan vakalardan bahsediliyor. Y\u0131l sonunda bu belki 1000 belki 1500 olabilir, kesin bir \u015fey s\u00f6ylemek zor. Ama bir art\u0131\u015f s\u00f6z konusu.” de\u011ferlendirmesini yapt\u0131.<\/p>\n
D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) ve UNICEF’in k\u0131zam\u0131k salg\u0131n\u0131 i\u00e7in “kusursuz f\u0131rt\u0131na” yorumunu yapt\u0131\u011f\u0131na i\u015faret eden D\u00f6kmeta\u015f, salg\u0131nlar\u0131n en b\u00fcy\u00fck nedeninin a\u015f\u0131 yapt\u0131rmamak veya a\u015f\u0131ya ula\u015famamak oldu\u011funu s\u00f6yledi. Prof. Dr. D\u00f6kmeta\u015f, Kovid-19 salg\u0131n\u0131 nedeniyle insanlar\u0131n hastanelerden uzakla\u015fmas\u0131 ve hekimlerin yeteri kadar a\u015f\u0131lama yapamamas\u0131n\u0131n da salg\u0131n\u0131n art\u0131\u015f\u0131nda etken oldu\u011funu ifade etti.<\/p>\n
Ayr\u0131ca Somali, Afganistan, Etiyopya gibi fakir ve altyap\u0131s\u0131 d\u00fczg\u00fcn olmayan baz\u0131 \u00fclkelerde a\u015f\u0131ya eri\u015fimde e\u015fitsizlik ya\u015fanmas\u0131na da dikkati \u00e7eken D\u00f6kmeta\u015f, bu sebeplerin d\u00fcnyada da k\u0131zam\u0131k salg\u0131n\u0131n\u0131n artmas\u0131na yol a\u00e7t\u0131\u011f\u0131n\u0131, \u00fclkeler aras\u0131nda ge\u00e7i\u015fe neden olabildi\u011fini kaydetti.<\/p>\n
Prof. Dr. \u0130lyas D\u00f6kmeta\u015f, t\u00fcm d\u00fcnyada ve T\u00fcrkiye’de k\u0131zam\u0131k a\u015f\u0131s\u0131n\u0131n y\u0131llardan beri yap\u0131ld\u0131\u011f\u0131n\u0131 ve yan etkilerinin yok denecek kadar az oldu\u011funu vurgulayarak, \u015funlar\u0131 kaydetti:<\/p>\n
“A\u015f\u0131lanmazsan\u0131z \u00f6ld\u00fcr\u00fcc\u00fc hastal\u0131\u011fa yakalanma oran\u0131 ve bu hastal\u0131\u011f\u0131 ge\u00e7iren ki\u015finin \u00e7evresine bula\u015ft\u0131r\u0131c\u0131l\u0131\u011f\u0131 da daha fazla. \u00c7\u00fcnk\u00fc k\u0131zam\u0131k enfeksiyon hastal\u0131klar\u0131 i\u00e7erisinde en y\u00fcksek bula\u015ft\u0131r\u0131c\u0131l\u0131k katsay\u0131s\u0131na sahip bir hastal\u0131k; 12-16 kat daha y\u00fcksek. \u015eu anda \u00fclkemizdeki k\u0131zam\u0131k g\u00f6r\u00fclme oran\u0131 Avrupa k\u0131tas\u0131n\u0131n en y\u00fcksek seviyesinde. D\u00fcnyan\u0131n di\u011fer \u00fclkelerinde ise bizden fazla olanlar var. \u00d6rne\u011fin; Rusya, Tacikistan veya Afrika \u00fclkelerinin bir\u00e7o\u011funda \u00e7ok y\u00fcksek rakamlar mevcut. Baz\u0131 aileler, ‘\u00c7ocu\u011fum do\u011fal yolla hastal\u0131\u011f\u0131 ge\u00e7irsin, a\u015f\u0131 olmasa da olur. A\u015f\u0131n\u0131n i\u00e7erisinde baz\u0131 istenmeyen maddeler var.’ diyor ki bunlar\u0131n do\u011fruluk pay\u0131 \u00e7ok yok. A\u015f\u0131lar\u0131n istenmeyen etkileri son derece az, koruyuculuk oran\u0131 son derece y\u00fcksek. ‘Do\u011fal olarak hastal\u0131\u011f\u0131 ge\u00e7irsin.’ dedi\u011finizde \u00e7ocu\u011funuz komplikasyonlarla zat\u00fcrreyle beyin iltihab\u0131yla \u00f6lebilir. \u00c7ocu\u011funuzun hastalanmas\u0131 sonucu toplumdaki k\u0131zam\u0131k a\u015f\u0131s\u0131n\u0131n koruyuculuk etkisinin d\u00fc\u015fmesiyle ba\u015fkalar\u0131 da hastalanabilir ve \u00f6lebilir. Hastan\u0131n \u00e7evresinde hamile biri varsa o da k\u0131zam\u0131k ge\u00e7irebilir ve do\u011facak \u00e7ocu\u011funda da komplikasyonlar olabilir. Bu mikroorganizman\u0131n, vir\u00fcs\u00fcn bula\u015fmas\u0131 hap\u015f\u0131rmayla \u00f6ks\u00fcr\u00fckle m\u00fcmk\u00fcn. B\u00f6yle bir durumda 1-2 haftal\u0131k vir\u00fcs\u00fcn \u00e7o\u011falma d\u00f6nemi denilen s\u00fcre\u00e7te, k\u0131zam\u0131k hastas\u0131n\u0131n yak\u0131n\u0131ndaki ki\u015fide de belirtiler ortaya \u00e7\u0131kabilir.”<\/p>\n
D\u00f6kmeta\u015f, k\u0131zam\u0131\u011fa kar\u015f\u0131 aile sa\u011fl\u0131\u011f\u0131 merkezlerinin iyi \u00e7al\u0131\u015fmas\u0131, hekimlerin hastalara ula\u015fmas\u0131, a\u015f\u0131n\u0131n \u00f6neminin bas\u0131n yay\u0131n organlar\u0131yla veya birebir anlat\u0131lmas\u0131 gerekti\u011fini vurgulayarak, a\u015f\u0131 olunmad\u0131\u011f\u0131nda k\u0131zam\u0131k artarken bununla yak\u0131n ili\u015fkisi olan su\u00e7i\u00e7e\u011fi gibi farkl\u0131 komplikasyonlar\u0131n da \u00e7\u0131kabildi\u011fini anlatt\u0131.<\/p>\n
Prof. Dr. \u0130lyas D\u00f6kmeta\u015f, k\u0131zam\u0131k vakalar\u0131ndaki art\u0131\u015fla ilgili panik yap\u0131lmamas\u0131 gerekti\u011fini, \u015fu anda b\u00fcy\u00fck bir salg\u0131n olmad\u0131\u011f\u0131n\u0131 dile getirdi. \u0130lerleyen s\u00fcre\u00e7te bunun salg\u0131na d\u00f6n\u00fc\u015f\u00fcp d\u00f6n\u00fc\u015fmeyece\u011fine y\u00f6nelik ise D\u00f6kmeta\u015f, “Bu bir \u00f6n salg\u0131n gibi veya korkulabilen, dikkat etmemiz gereken bir hastal\u0131k diyebiliriz. Fakat bu art\u0131\u015f b\u00f6yle devam ederse ka\u00e7\u0131n\u0131lmaz bir hasta y\u00fck\u00fcyle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131r\u0131z. Sadece k\u0131zam\u0131ktan de\u011fil k\u0131zam\u0131\u011f\u0131n istenmeyen etkilerinden, hastal\u0131\u011f\u0131n komplikasyonlar\u0131ndan veya di\u011fer viral enfeksiyonlar ve d\u00f6k\u00fcnt\u00fcl\u00fc hastal\u0131klardan kaybetti\u011fimiz insanlar olabilir.” de\u011ferlendirmesini yapt\u0131.<\/p>\n
T\u00fcrkiye’de a\u015f\u0131ya eri\u015fimde devlet, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 ya da s\u00fcre\u00e7 baz\u0131nda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 belirten D\u00f6kmeta\u015f, “Ancak bireylerin a\u015f\u0131lanmaya yeteri kadar gelmemesi ve Kovid-19 salg\u0131n\u0131ndan dolay\u0131 ba\u015fka i\u015flerle u\u011fra\u015fma s\u00fcrecinde baz\u0131 aksamalar\u0131n olmas\u0131 nedeniyle k\u0131zam\u0131k a\u015f\u0131s\u0131n\u0131n koruyuculuk oranlar\u0131, etkileri d\u00fc\u015fm\u00fc\u015f olabilir.” diye konu\u015ftu.<\/p>\n
Bir ki\u015fide ate\u015f ve d\u00f6k\u00fcnt\u00fc varsa mutlaka hekime ba\u015fvurulmas\u0131n\u0131n, k\u0131zam\u0131ktan \u015f\u00fcphelenen hekimin ise bula\u015f\u0131 \u00f6nlemek i\u00e7in koruyucu \u00f6nlemler almas\u0131 gerekti\u011fini s\u00f6yleyen D\u00f6kmeta\u015f, hastan\u0131n veya ay\u0131r\u0131c\u0131 tan\u0131 konan ki\u015finin komplikasyonlara ya da ileri d\u00f6nemde g\u00f6r\u00fclebilecek ve beyinde ciddi hasarlarla seyreden “SSPE” ve “ADEM” denilen hastal\u0131klara kar\u015f\u0131 takip edilmesi, ayr\u0131ca hastayla yak\u0131n temasl\u0131 ki\u015filerin de k\u0131zam\u0131\u011fa kar\u015f\u0131 ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n\u0131n incelenmesi gerekti\u011fini s\u00f6zlerine ekledi.<\/p>\n
Medipol \u00dcniversitesi \u00c7aml\u0131ca Hastanesi \u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Uzman\u0131 Dr. \u00d6\u011fretim \u00dcyesi G\u00f6kmen Alpaslan Ta\u015fk\u0131n ise Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 \u00c7ocukluk D\u00f6nemi A\u015f\u0131 Takvimi’nde yer alan ve rutin olarak t\u00fcm \u00e7ocuklara \u00fccretsiz uygulanan k\u0131zam\u0131k a\u015f\u0131s\u0131n\u0131n ihmal edilmemesi gerekti\u011fini s\u00f6yledi.<\/p>\n
Son d\u00f6nemde a\u015f\u0131 reddinin artmaya ba\u015flad\u0131\u011f\u0131n\u0131, baz\u0131 ailelerin \u00e7ocuklara yap\u0131lmas\u0131 gereken t\u00fcm a\u015f\u0131lar\u0131 reddetti\u011fini belirten Ta\u015fk\u0131n, bu nedenle \u00e7ocuklar\u0131n risk alt\u0131nda kalabildi\u011fine dikkati \u00e7ekti.<\/p>\n
A\u015f\u0131 reddine dezenformasyonun yol a\u00e7t\u0131\u011f\u0131n\u0131, ailelerce a\u015f\u0131lar\u0131n \u00e7ocuklar\u0131nda otizme ya da farkl\u0131 sa\u011fl\u0131k sorunlar\u0131na yol a\u00e7abilece\u011finin d\u00fc\u015f\u00fcn\u00fcld\u00fc\u011f\u00fcn\u00fc anlatan Ta\u015fk\u0131n, \u015f\u00f6yle devam etti:<\/p>\n
“Bu yeni de\u011fil y\u0131llard\u0131r olan bir a\u015f\u0131. Rutin a\u015f\u0131lama programlar\u0131n\u0131 sanki sa\u011fl\u0131kl\u0131 bir \u00e7ocu\u011fa mikrop enjekte ediliyormu\u015f gibi d\u00fc\u015f\u00fcn\u00fcyorlar. Zay\u0131flat\u0131lm\u0131\u015f mikrop veriliyor ama bunun amac\u0131 v\u00fccudun o mikropla tan\u0131\u015fmas\u0131, v\u00fccut bu mikropla ger\u00e7ekten kar\u015f\u0131la\u015ft\u0131\u011f\u0131nda da onu alt edebilmesi… Dezenformasyonun yan\u0131 s\u0131ra a\u015f\u0131n\u0131n i\u00e7erisinde katk\u0131 maddesi oldu\u011fu d\u00fc\u015f\u00fcncesinden de kaynaklan\u0131yor. Halbuki eser miktarda baz\u0131 maddeler var ve bunlarla g\u00fcnl\u00fck kulland\u0131\u011f\u0131m\u0131z g\u0131dalarda da kar\u015f\u0131la\u015fabiliyoruz. K\u0131zam\u0131ktan korunmak i\u00e7in \u00f6ncelikle a\u015f\u0131s\u0131n\u0131 zaman\u0131nda yapt\u0131rmal\u0131y\u0131z. Genelde 1 ve 4 ya\u015flar\u0131nda yap\u0131l\u0131yor ama \u00f6zellikle riskin artt\u0131\u011f\u0131 durumlarda 4 ya\u015f\u0131nda yap\u0131lacak a\u015f\u0131 9’uncu aya \u00e7ekilebiliyor. K\u0131zam\u0131k, k\u0131zam\u0131k\u00e7\u0131k, kabakulak genelde beraber yap\u0131l\u0131yor.”<\/p>\n
Dr. \u00d6\u011fretim \u00dcyesi Ta\u015fk\u0131n, k\u0131zam\u0131k vakalar\u0131nda art\u0131\u015f ya\u015fan\u0131p ya\u015fanmad\u0131\u011f\u0131na y\u00f6nelik de\u011ferlendirmesinde, “D\u00f6k\u00fcnt\u00fcl\u00fc hastal\u0131klarda art\u0131\u015f var ki bizim de \u015f\u00fcphelendiklerimiz oluyor. Son aylarda belki 1-2 hastam\u0131z pozitif geldi diye hat\u0131rl\u0131yorum ama en az\u0131ndan bizim hastanemiz d\u00fczeyinde \u00e7ok yo\u011fun vaka g\u00f6rmedik. Fakat \u00e7evreden duyuyoruz, devlet ve e\u011fitim ara\u015ft\u0131rma hastanesinde \u00e7al\u0131\u015fanlar daha \u00e7ok vakayla kar\u015f\u0131la\u015f\u0131yor.” ifadelerini kulland\u0131.<\/p>\n
Ta\u015fk\u0131n, A vitamini eksikli\u011fi olan \u00e7ocuklar\u0131n k\u0131zam\u0131\u011f\u0131 a\u011f\u0131r ge\u00e7irip zat\u00fcrreye yakalanabildiklerine dikkati \u00e7ekerek, A vitamini takviyesi ve bu vitaminden zengin g\u0131dalar alman\u0131n komplikasyonu \u00f6nlemede koruyucu olabilece\u011fini belirtti.<\/p>\n